Get the app
public
ios_share
OncoPharm
chevron_right
ADAM VTE & Ibrutinib CV Toxicity
Oct 24, 2019
18:10
forum
Ask episode
play_arrow
Play
view_agenda
Chapters
auto_awesome
Transcript
info_circle
Episode notes
ADAM VTE (apixaban for cancer-associated VTE) results have been published - let's talk about it. Also, what are the implications of long term ibrutinib on CV health? A new Blood paper offers some possible answers.